Incidental detection of ductal carcinoma in situ of the breast from bilateral prophylactic mastectomy of asymptomatic BRCA2 mutation carrier: A case report

Journal of Breast Cancer

Volumn 13, Issue 3, 2010, Pages 311-317

  Choi, Min Young ^a   Lee, Jeong Eon ^a   Kim, Sung Won ^b   Lee, Se Kyung ^a   Hur, Sung Mo ^a   Kim, Sangmin ^a   Koo, Min Young ^a   Bae, Soo Youn ^a   Choe, Jun Ho ^a   Kim, Jung Han ^a   Kim, Jee Soo ^a   Nam, Seok Jin ^a   Yang, Jung Hyun ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

Bilateral mastectomy; BRCA2 gene mutation; Breast neoplasms; Hereditary; Prevention

Indexed keywords

BRCA2 PROTEIN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER SCREENING; CASE REPORT; FEMALE; GENE MUTATION; GENETIC SCREENING; HETEROZYGOTE; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MASTECTOMY; OVARY CANCER; SENTINEL LYMPH NODE BIOPSY;

EID: 78249271047     PISSN: 17386756     EISSN: None     Source Type: Journal    
DOI: 10.4048/jbc.2010.13.3.311     Document Type: Article

References (22)

1. Finch A, Beiner M, Lubinski J, Lynch HT, Moller P, Rosen B, et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. JAMA 2006;296: 185-92.
2. Narod SA, Offit K. Prevention and management of hereditary breast cancer. J Clin Oncol 2005;23:1656-63.
3. Gahm J, Jurell G, Edsander-Nord A, Wickman M. Patient satisfaction with aesthetic outcome after bilateral prophylactic mastectomy and immediate reconstruction with implants. J Plast Reconstr Aesthet Surg 2010;63:332-8.
4. Tan MB, Bleiker EM, Menke-Pluymers MB, Van Gool AR, van Dooren S, Van Geel BN, et al. Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy. Hered Cancer Clin Pract 2009; 7:6.
5. Kim KS, Kim S, Han SA, Kang E, Jeon YT, Ha TH, et al. Contralateral propylactic mastectomy and prophylactic salphingo-oophorectomy in a BRCA1-positive breast cancer patient: a case report. J Breast Cancer 2008;11:218-22.
6. Hahn HM, Yeom TH, Shin YW, Kim KH, Youn DJ, Jung KJ. A standardization study of beck depression inventory in Korea. J Korean Neuropsychiatr Assoc 1986;25:487-502.
7. Scheier MF, Carver CC, Bridges MW. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. J Pers Soc Psychol 1994;67: 1063-78.
8. Han DW, Lee CH, Tark JK. Standardization of Spielberger's anxiety test. Korean Psychological Association. http://www.koreanpsychology.or.kr. accessed March 20th, 2010.
9. John EW. SF-36 Health Survey Update. A community for measureing health outcomes using SF tools. http://www.sf-36.org. accessed March 20th, 2010.
10. Healey EA, Cook EF, Orav EJ, Schnitt SJ, Connolly JL, Harris JR. Contralateral breast cancer: clinical characteristics and impact on prognosis. J Clin Oncol 1993;11:1545-52.
11. Kollias J, Ellis IO, Elston CW, Blamey RW. Clinical and histological predictors of contralateral breast cancer. Eur J Surg Oncol 1999;25: 584-9.
12. Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol 2007;25:5203-9.
13. Hoogerbrugge N, Bult P, de Widt-Levert LM, Beex LV, Kiemeney LA, Ligtenberg MJ, et al. High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer. J Clin Oncol 2003;21:41-5.
14. Isern AE, Loman N, Malina J, Olsson H, Ringberg A. Histopathological findings and follow-up after prophylactic mastectomy and immediate breast reconstruction in 100 women from families with hereditary breast cancer. Eur J Surg Oncol 2008;34:1148-54.
15. Kauff ND, Brogi E, Scheuer L, Pathak DR, Borgen PI, Hudis CA, et al. Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations. Cancer 2003;97:1601-8.
16. Brandberg Y, Sandelin K, Erikson S, Jurell G, Liljegren A, Lindblom A, et al. Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study. J Clin Oncol 2008;26: 3943-9.
17. Ashikari RH, Ashikari AY, Kelemen PR, Salzberg CA. Subcutaneous mastectomy and immediate reconstruction for prevention of breast cancer for high-risk patients. Breast Cancer 2008;15:185-91.
18. Garcia-Etienne CA, Cody Iii HS 3rd, Disa JJ, Cordeiro P, Sacchini V. Nipple-sparing mastectomy: initial experience at the Memorial Sloan-Kettering Cancer Center and a comprehensive review of literature. Breast J 2009;15:440-9.
19. Boughey JC, Cormier JN, Xing Y, Hunt KK, Meric-Bernstam F, Babiera GV, et al. Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy. Cancer 2007;110:2542-50.
20. Dupont EL, Kuhn MA, McCann C, Salud C, Spanton JL, Cox CE. The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy. Am J Surg 2000;180:274-7.
21. Schrag D, Kuntz KM, Garber JE, Weeks JC. Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations. JAMA 2000;283:617-24.
22. Kim KS, Kim SW, Lee MH, Ahn SH, Park SK; Korean Breast Cancer Society. Practice patterns of surgeons for the management of hereditary breast cancer in Korea. J Breast Cancer 2008;11:95-101.